Preparing your space
Preparing your space
Find current and older curated stories in one place.
3114 resources
![]({"$":{"href":"https://static.libsyn.com/p/assets/7/b/2/f/7b2f0144e4518357d959afa2a1bf1c87/ASCO_Daily_News-Podcast-Icon26_1.png"}})
ASCO Daily News · Podcast
Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC. LINK TO FULL TRANSCRIPT
Cancer Health — Science · Research
Findings published in NEJM and presented at ASCO 2026 show the bispecific immunotherapy significantly outperformed standard treatments.
ScienceDaily — Cancer · Research
A newly identified protein may be one of the biggest obstacles holding CAR T-cell therapy back. Researchers found that NFIL3 causes these engineered immune cells to become exhausted and lose their cancer-fighting power over time. When NFIL3 was disabled, the cells remained stronger for longer and controlled tumors more effectively in animal models.
Mayo Clinic on Nutrition · Podcast
One in 10 U.S. adults has at least one food allergy. While many involve familiar triggers like peanuts or shellfish, more than 170 foods have been linked to allergic reactions. So why do food allergies seem more common than ever? And what should you do if one develops in adulthood? On this episode of On Nutrition, registered dietitian Sara Wolf answers common food allergy questions and shares how
Healthy Lifestyle · Article
Cancer Nutrition · Article
Healthy Lifestyle · Research
Nutrition & Anti-Inflammatory Eating · Article
ScienceDaily — Cancer · Article
A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how much. Researchers found that oleic acid—the main fat in olive oil and several other common foods—sped up tumor growth in mice predisposed to pancreatic cancer, while omega-3-rich fats from fish oil dramatically slowed disease development.
Oncology Brothers · Podcast
Join us as we bring you the latest insights from ASCO 2026! In this episode, we dived deep into the groundbreaking RASolute-302 study, which has made waves in the treatment of metastatic pancreatic cancer. Discover how the novel RAS inhibitor, Daraxonrasib, has doubled overall survival rates from 6.7 months to an impressive 13.2 months for patients in the second-line setting. Listen us on:Spotify:
MD Anderson Cancer Center · Video
ASCO Daily News · Podcast
Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma. LINK TO TRANSCRIPT
Cancer Health — Science · Research
Targeted RET inhibitor Retevmo can help prevent early-stage RET-positive non-small cell lung cancer from returning after standard treatment.
Autoimmune & Inflammation · Research
Sleep & Rest · Article
Cancer Research News · Research
Chronic Condition Research · Research
Cancer Research News · Research
ASCO Daily News · Podcast
Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma. LINK TO FULL TRANSCRIPT
Oncology Patient Care · Research
Immunotherapy Updates · Research
Cancer Research News · Research
Cancer Research News · Research
ASCO Daily News · Podcast
Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer. LINK TO FULL TRANSCRIPT